Oxidative Stress and Inflammation: Their Role in the Pathogenesis of Peripheral Artery Disease with or without Type 2 Diabetes Mellitus

被引:33
作者
Signorelli, Salvatore Santo [1 ]
Katsiki, Niki [2 ]
机构
[1] Univ Catania, G Rodolico Univ Hosp, Internal Med Div, Dept Clin & Expt Med,Med Sch, Catania, Italy
[2] Aristotle Univ Thessaloniki, Hippocrat Hosp, Med Sch, Dept Propaedeut Internal Med 2, Thessaloniki, Greece
关键词
Peripheral artery disease; type 2 diabetes mellitus; oxidative stress; inflammation; antioxidant; CV; C-REACTIVE PROTEIN; LOWER-EXTREMITY AMPUTATION; PROPIONYL-L-CARNITINE; ANKLE-BRACHIAL INDEX; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; MACROVASCULAR DISEASE; MOLECULAR-MECHANISMS;
D O I
10.2174/1570161115666170731165121
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Peripheral Artery Disease (PAD), a common vascular disease, has been associated with increased Cardiovascular (CV) morbidity and mortality as well as all-cause death. Type 2 Diabetes Mellitus (T2DM) predisposes to PAD development. In T2DM patients, PAD further increases the risk for CV disease and death as well as foot morbidity and microvascular complications. The present narrative review discusses the role of oxidative stress and inflammation in the pathophysiology of PAD with or without the presence of T2DM. The effects of lifestyle measures (i.e. diet, physical activity and smoking cessation) and drug treatment on markers of oxidative stress and inflammation are also considered. Further research should establish the clinical implications of such effects as well as the clinical use of antioxidants and anti-inflammatory drugs in PAD.
引用
收藏
页码:547 / 554
页数:8
相关论文
共 147 条
[1]   The Association of Active and Passive Smoking With Peripheral Arterial Disease: Results From NHANES 1999-2004 [J].
Agarwal, Shikhar .
ANGIOLOGY, 2009, 60 (03) :335-345
[2]   All for Statins and Statins for All; An Update [J].
Agouridis, Aris P. ;
Elisaf, Moses S. ;
Nair, Devaki R. ;
Mikhailidis, Dimitri P. .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (01) :18-27
[3]   Cilostazol reduces inflammatory burden and oxidative stress in hypertensive type 2 diabetes mellitus patients [J].
Agrawal, Neeraj K. ;
Maiti, Rituparna ;
Dash, D. ;
Pandey, B. L. .
PHARMACOLOGICAL RESEARCH, 2007, 56 (02) :118-123
[4]   Abdominal Aortic Diameter and the Risk for Asymptomatic Peripheral Arterial Disease in Patients with Type 2 Diabetes [J].
Amer, Moatasem Salah ;
Omar, Omar Hussien ;
Reda, Randa Abdel Wahab ;
Rahman, Tomader Taha Abdel ;
Rasheedy, Doha .
INTERNATIONAL JOURNAL OF ANGIOLOGY, 2015, 24 (02) :113-119
[5]   Adipokines as Drug Targets in Diabetes and Underlying Disturbances [J].
Andrade-Oliveira, Vincius ;
Camara, Niels O. S. ;
Moraes-Vieira, Pedro M. .
JOURNAL OF DIABETES RESEARCH, 2015, 2015
[6]   The Burden of Peripheral Artery Disease and the Role of Antiplatelet Therapy [J].
Aronow, Herbert ;
Hiatt, William R. .
POSTGRADUATE MEDICINE, 2009, 121 (04) :123-135
[7]  
Aronson D, 2008, ADV CARDIOL, V45, P1, DOI 10.1159/000115118
[8]   Do Some Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) Reduce Macrovascular Complications of Type 2 Diabetes Mellitus? A Commentary on the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial [J].
Athyros, Vasilios G. ;
Katsiki, Niki ;
Tentolouris, Nikolaos .
CURRENT VASCULAR PHARMACOLOGY, 2016, 14 (05) :469-473
[9]   Combination of Statin Plus Renin Angiotensin System Inhibition for the Prevention or the Treatment of Atherosclerotic Cardiovascular Disease [J].
Athyros, Vasilios G. ;
Katsiki, Niki ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (40) :6299-6305
[10]   Pleiotropic Effects of Statins - Clinical Evidence [J].
Athyros, Vasilios G. ;
Kakafika, Anna I. ;
Tziomalos, Konstantinos ;
Karagiannis, Asterios ;
Mikhailidis, Dimitri P. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (05) :479-489